NCT05240976 Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia Status RECRUITING Phase PHASE2
NCT05233657 A Safety,Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule Status UNKNOWN Phase PHASE1
NCT05229484 Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia Status COMPLETED Phase NA
NCT05227703 A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia Status COMPLETED Phase PHASE2
NCT05227690 A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia Status COMPLETED Phase PHASE2
NCT05213143 The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine Status TERMINATED Phase PHASE4
NCT05211947 A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study Status TERMINATED Phase PHASE3
NCT05208190 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial Status RECRUITING Phase PHASE4
NCT05208021 The Effect of Psychoeducation Program on Healthy Living Behaviors Status UNKNOWN Phase NA
NCT05207319 Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia Status COMPLETED Phase NA
NCT05206734 Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health Status COMPLETED Phase N/A
NCT05206292 Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders. Status RECRUITING Phase NA
NCT05200962 Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05193578 Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes Status COMPLETED Phase PHASE2
NCT05192304 Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia Status UNKNOWN Phase PHASE1
NCT05184335 Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia Status RECRUITING Phase PHASE3
NCT05182476 Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia Status TERMINATED Phase PHASE2